Aigen Investment Management, LP Natera, Inc. Transaction History

Aigen Investment Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$85.28 - $112.6 $77,178 - $101,903	905 Added 22.33%	4,957 $536,000
Q1 2024 May 14, 2024	BUY	$59.21 - $92.9 $239,918 - $376,430	4,052 New	4,052 $370,000
Q3 2023 Nov 13, 2023	BUY	$43.4 - $62.52 $219,083 - $315,600	5,048 New	5,048 $223,000
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $440,705 - $702,452	-12,051 Reduced 40.08%	18,014 $1 Million
Q4 2022 Feb 10, 2023	BUY	$34.17 - $47.91 $1.03 Million - $1.44 Million	30,065 New	30,065 $1.21 Million
Q3 2021 Nov 12, 2021	SELL	$100.17 - $126.36 $310,426 - $391,589	-3,099 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$86.05 - $119.72 $266,668 - $371,012	3,099 New	3,099 $352,000
Q2 2020 Aug 10, 2020	SELL	$26.36 - $49.86 $216,679 - $409,849	-8,220 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$17.27 - $40.17 $423,063 - $984,044	-24,497 Reduced 74.88%	8,220 $245,000
Q4 2019 Feb 04, 2020	BUY	$32.1 - $40.4 $1.05 Million - $1.32 Million	32,717 New	32,717 $1.1 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.